Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06860724 · ClinicalTrials.gov registry record · NA

Linking Affective Dynamics in Response to Daily Stress to Peripheral Vascular Function in Working Age Adults

A NA study of Major Depressive Disorder, sponsored by University of Delaware.

Recruiting
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT06860724 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 18 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06860724, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by University of Delaware.

RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The objective of this proposal is to determine whether heightened negative affective responsivity (NA-R) to daily stressors is related to blunted nitric oxide (NO)-mediated endothelium-dependent dilation (EDD) in working age adults and the extent to which this association is impacted by major depressive disorder (MDD).

Conditions Studied

Interventions

  • OTHER NG-nitro-L-arginine methyl ester (L-NAME)

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2025-01-06
Est. Completion 2031-12-01
Phase NA

Sponsor

University of Delaware

106 total trials

What the Registry Record Tells You About NCT06860724

The ClinicalTrials.gov registry entry for NCT06860724 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (95% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which NG-nitro-L-arginine methyl ester (L-NAME) is the first listed.

NCT06860724 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT06860724 about?

NCT06860724 is a clinical study titled "Linking Affective Dynamics in Response to Daily Stress to Peripheral Vascular Function in Working Age Adults". The objective of this proposal is to determine whether heightened negative affective responsivity (NA-R) to daily stressors is related to blunted nitric oxide (NO)-mediated endothelium-dependent dilation (EDD) in working age adults and the extent to which this association is impacted by major depres...

What is the current status of trial NCT06860724?

This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2025-01-06. Estimated completion is 2031-12-01.

What conditions does trial NCT06860724 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT06860724?

The interventions under investigation include: NG-nitro-L-arginine methyl ester (L-NAME) (OTHER).

Who is sponsoring clinical trial NCT06860724?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06860724 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.